Hear the surprising results of a homegrown clinical research trial using selective antimicrobials to create shifts in gut and metabolic pathology.
Join BioConcepts’ own Katey Weekes for a clinical immersion, jam-packed with conventional and functional pathology interpretation and discover the patient outcomes that can be achieved with less intervention.
Whether it is multiple dysbiotic species, low beneficial flora, SIBO, IBS or a blend of many, our obsession with ‘killing’ the bad bugs has led us down a path that could be doing more harm than good. Could selective options be the evolution we needed?